Acute Myeloid Leukemia – Epidemiology – Middle East & Africa Data

  • The total number of incident cases of AML (excluding APL) in the countries under study will increase by 33% over the forecast period, from 1,500 in 2017 to 2,000 in 2027.
  • The total number of incident cases of APL in the countries under study will increase by 30% over the forecast period, from 200 in 2017 to 250 in 2027.
  • 25% of diagnosed incident cases of AML in these markets have the FLT3ITD mutation, and 5% have the FLT3-TKD mutation.

Table of contents

  • Acute Myeloid Leukemia - Epidemiology - Middle East & Africa Data
    • Introduction
      • Key Findings
        • Overview
          • Diagnosed Incidence of Acute Myeloid Leukemia per 100,000 People of All Ages per Year in 2017 and 2027tttttttttttttttttttttt
          • Diagnosed Incidence of Acute Promyelocytic Leukemia per 100,000 People of All Ages per Year in 2017 and 2027ttttttttt
          • Relative Sizes of the Factors Contributing to the Trend in Incident Cases of Acute Myeloid Leukemia over the Next Ten Yearsttttttttt
          • Relative Sizes of the Factors Contributing to the Trend in Incident Cases of Acute Promyelocytic Leukemia over the Next Ten Yearsttttttttt
          • Number of Additional Incident Cases of Acute Myeloid Leukemia Incurred over 2017-2027 in the Countries Under Studyttttttttt
      • Epidemiology Data
      • Methods
        • Diagnosed Prevalent Cases
        • Newly Diagnosed Incident Cases
        • FLT-3 Mutation
        • Lifetime DALYs Gained
      • Reference Materials
        • Literature Review
          • Studies Included in the Analysis of Acute Myeloid Leukemia
          • Studies Excluded from the Analysis of Acute Myeloid Leukemia
        • Risk/Protective Factors
          • Risk/Protective Factors for Acute Myeloid Leukemia
        • Bibliography